OVERCOMING COMMON CHALLENGES IN THE ED

using with-patient testing solutions

INCREASING CHALLENGES IN EMERGENCY CARE

The demand for high-quality, efficient healthcare is escalating. Care systems are often faced with overcrowding and other operational, clinical or financial challenges. They need every resource available to support care while trying to overcome these increasing obstacles. Abbott Point of Care, with its i-STAT blood analysers offers solutions to help meet the growing challenges faced by EDs worldwide.

The i-STAT 1 and i-STAT Alinity systems bring testing to wherever it's needed, allowing medical staff to expedite care by performing a wide range of diagnostic tests at the patient's bedside within minutes, rather than hours, using only a few drops of blood.

HELP OPTIMISE PATIENT CARE WITH   i-STAT

ACHIEVING MAXIMUM CARE WITH MINIMUM WAIT

ED overcrowding puts stress on caregivers and is a major patient safety concern associated with poor patient outcomes.1  Increased ED volume can mean patients face long periods of waiting.2

In the ED, the optimal patient journey should include a maximum amount of care with minimum wait, thus hospitals are challenged to find ways to improve patient-care workflows to expedite care and reduce overcrowding. Implementing the i-STAT System can help accomplish this.

FACILITATE REAL-TIME DECISIONS IN DIVERSE SETTINGS TO OPTIMISE CARE

i‑STAT test cartridges provide clinicians with fast results that aid in early identification of patients with urgent treatment needs or deteriorating health and can help to identify those that are critically ill. The handheld nature of the i-STAT 1 and i-STAT Alinity  analysers means blood testing can be performed at the patient’s bedside, potentially reducing the risk of contamination and cross-infection.

*The results shown in studies featured on this page are specific to this health care facility and may differ from those achieved by other institutions.

POINT-OF-CARE TESTING CAN PROVIDE UP TO

42%

REDUCTION IN ED OVERCROWDING 2

 

i-STAT HAS BEEN SHOWN TO IMPROVE DOOR-TO-DISPOSITION TIMES BY
41%.2*

USE OF THE i-STAT SYSTEM CAN ALSO PROVIDE FINANCIAL OUTCOMES THROUGH INCREASED EFFICIENCIES IN THE ED AND THROUGHOUT THE ENTIRE HOSPITAL

A BROAD RANGE OF DIAGNOSTIC TESTS WHEN AND WHERE THEY ARE NEEDED

Requiring only a few drops of blood and the single-use test cartridges, i-STAT analysers deliver real-time, laboratory-quality results. Testing where and when tests are needed helps foster a collaborative, patient-centered environment, while driving improved operational performance by streamlining the testing process to help accelerate patient-care decision-making.

THE i-STAT SYSTEM RANGE OF TEST CARTRIDGES
LACTATE
CG4+
HAEMATOLOGY
CG8+, EG7+, E3+, EC4+, 6+, EC8+, EG6+, CHEM8+
CHEMISTRIES & ELECTROLYTES
CHEM8+, EG7+, G, Crea, E3+, EC4+, 6+, EC8+, EG6+, CG8+
CARDIAC MARKERS
cTnl, CK-MB, BNP
ENDOCRINOLOGY
Total β-hCG
BLOOD GASES
EG7+, CG8+, G3+, EG6+, CG4+
COAGULATION
PT/INR, ACT Kaolin, ACT Celite®

Celite® is a registered trademark of Celite Corporation

WANT TO KNOW MORE ABOUT i-STAT SOLUTIONS?

EMERGENCY MEDICINE RESOURCES
ABBOTT POINT OF CARE OFFERS RESOURCES, SUCH AS ARTICLES, PRODUCT INFORMATON, EDUCATIONAL VIDEOS, WEBINARS AND CASE STUDIES FOR EMERGENCY PROFESSIONALS TO VIEW, LEARN AND SHARE. SOME OF THESE RESOURCES ARE HIGHLIGHTED BELOW.

EFFICIENCY MAKES A DIFFERENCE

References:

  1. Carter EJ et al. J Nurs Scholarsh 2014;46:106-15.
  2. Jarvis PRE et al. Br J Hospit Med 2014;75:397-400.
  3. Abbott Point of Care.“Point-of-care testing reduces ED assessment steps and improves patient throughput.” 2180.1
  4. Bailey TM et al. Jt Comm J Qual Improv 1997;23:302-80.
  5. NHS Institute for Innovation and Improvement. Ambulatory care directory for adult patients. 2009.
  6. Royal College of Physicians. Acute Medical Care – the right person, in the right setting – first time. Report of the Acute Medicine Task Force 2007. London. Available at: www.rcplondon.ac.uk/sites/default/files/documents/acute_medical_care_final_for_web.pdf [Accessed May 2019].